Cardiology Measures 2026

  • QPP5: Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
  • QPP7: Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF ≤ 40%)
  • QPP6: Coronary Artery Disease (CAD): Antiplatelet Therapy
  • QPP8: Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
  • QPP130: Documentation of Current Medications in the Medical Record
  • QPP118: Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF ≤ 40%)
  • QPP238: Use of High-Risk Medications in Older Adults
  • QPP431: Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling
  • QPP344: Rate of Carotid Endarterectomy (CEA) or Carotid Artery Stenting (CAS) for Asymptomatic Patients, Without Major Complications (Discharged to Home by Post-Operative Day #2)
  • QPP236: Controlling High Blood Pressure
  • QPP47: Advance Care Plan
  • QPP495: Ambulatory Palliative Care Patients’ Experience of Feeling Heard and Understood
  • QPP326: Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy
  • QPP493: Adult Immunization Status
  • QPP226: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
  • QPP317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
  • QPP503: Gains in Patient Activation Measure (PAM) Scores at 12 Months
  • QPP441: Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control)
  • QPP438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
  • QPP393: Infection within 180 Days of Cardiac Implantable Electronic Device (CIED) Implantation, Replacement, or Revision
  • QPP392: Cardiac Tamponade and/or Pericardiocentesis Following Atrial Fibrillation Ablation
  • QPP374: Closing the Referral Loop: Receipt of Specialist Report
  • QPP243: Cardiac Rehabilitation Patient Referral from an Outpatient Setting
  • QPP187: Stroke and Stroke Rehabilitation: Thrombolytic Therapy
  • AVBC2: Echocardiogram Stewardship in Congestive Heart Failure (CHF): Avoiding Repeat Tests without Clinical Indication
  • AVBC3: SGLT2 Inhibitors for Patients with Chronic Kidney Disease (CKD) with or without Type 2 Diabetes Mellitus
  • AVBC4: Noninvasive Ischemic Imaging Stewardship in Chronic Coronary Disease: Avoiding Testing without Clinical Indication